HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DOTA(0)-Tyr(3)-Thr(8)- 90Y-octreotate

for use in radionuclide therapy
Also Known As:
90Y-octreotate, DOTA(0)-Tyr(3)-Thr(8)-; 90Y-(DOTA(0),Phe1,Tyr3)-octreotate; 90Y-DOTATATE
Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Banerjee, Sharmila: 3 articles (03/2021 - 09/2020)
2. Basu, Sandip: 3 articles (03/2021 - 09/2020)
3. Mitra, Arpit: 3 articles (03/2021 - 09/2020)
4. Upadhye, Trupti: 2 articles (03/2021 - 09/2020)
5. Parghane, Rahul V: 2 articles (01/2021 - 09/2020)
6. Rakshit, Sutapa: 2 articles (01/2021 - 09/2020)
7. Buscombe, John R: 1 article (04/2021)
8. Glinka, Lidia: 1 article (04/2021)
9. Kolasińska-Ćwikła, Agnieszka: 1 article (04/2021)
10. Nowicki, Mirosław L: 1 article (04/2021)

Related Diseases

1. Neoplasms (Cancer)
2. Neuroendocrine Tumors (Neuroendocrine Tumor)

Related Drugs and Biologics

1. Peptide Receptors (Peptide Receptor)
2. Radioisotopes (Radionuclides)
3. lutetium Lu 177 dotatate

Related Therapies and Procedures

1. Therapeutics